Characterization of 2′-deoxycytidine adducts derived from 4-oxo-2-nonenal, a novel lipid peroxidation product

Chemical Research in Toxicology

Volumn 16, Issue 7, 2003, Pages 893-900

  Pollack, Michael ^a   Oe, Tomoyuki ^a   Lee, Seon Hwa ^a   Elipe, Maria Victoria Silva ^b   Arison, Byron H ^b   Blair, Ian A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 OXO 2 NONENAL; CARCINOGEN; DEOXYCYTIDINE; UNCLASSIFIED DRUG; VINYL CHLORIDE; 4-OXO-2-NONENAL; ALDEHYDE; DRUG DERIVATIVE;

ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; COLON POLYP; DNA ADDUCT; DNA DAMAGE; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; SKIN CANCER; SYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; ISOMERISM; PH; TEMPERATURE;

ANIMALIA;

ALDEHYDES; CHROMATOGRAPHY, LIQUID; DEOXYCYTIDINE; HYDROGEN-ION CONCENTRATION; ISOMERISM; LIPID PEROXIDATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR STRUCTURE; TEMPERATURE;

EID: 0042308463     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx030009p     Document Type: Article

References (44)

1. Ames, B. N., Gold, L. S., and Willett, W. C. (1995) The causes and prevention of cancer. Proc. Natl. Acad. Sci. U.S.A. 92, 5258-5265.
2. Marnett, L. J. (2000) Oxyradicals and DNA damage. Carcinogenesis 21, 361-370.
3. Porter, N. A., Caldwell, S. E., and Mills, K. A. (1995) Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30, 277-290.
4. Hsi, L. C., Wilson, L., Nixon, J., and Eling, T. E. (2001) 15-Lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor g via the MAPK signaling pathway. J. Biol. Chem. 276, 34545-34552.
5. Marnett, L. J., and DuBois, R. N. (2002) COX-2: a target for colon cancer prevention. Annu. Rev. Pharmacol. Toxicol. 42, 55-80.
6. Lee, S. H., and Blair, I. A. (2000) Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem. Res. Toxicol. 13, 698-702.
7. Lee, S. H., Oe, T., and Blair, I. A. (2001) Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 292, 2083-2086.
8. Blair, I. A. (2001) Lipid hydroperoxide-mediated DNA damage. Exp. Gerontol. 36, 1473-1481.
9. Burcham, P. C. (1998) Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts. Mutagenesis 13, 287-305.
10. Winter, C. K., Segall, H. J., and Haddon, W. F. (1986) Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res. 46, 5682-5686.
11. Rindgen, D., Nakajima, M., Wehrli, S., Xu, K., and Blair, I. A. (1999) Covalent modifications to 2κ-deoxyguanosine by 4-oxo-2-nonenal a novel product of lipid peroxidation. Chem. Res. Toxicol. 12, 1195-1204.
12. 6-etheno-2′-deoxyadenosine adduct by lipid hydroperoxide-mediated generation of 4-oxo-2-nonenal. Chem. Res. Toxicol. 13, 846-852.
13. Lee, S. H., Rindgen, D., Bible, R. A., Hajdu, E., and Blair, I. A. (2000) Characterization of 2′-deoxyadenosine adducts derived from 4-oxo-2-nonenal, a novel product of lipid peroxidation. Chem. Res. Toxicol. 13, 565-574.
14. Green, T., and Hathway, D. E. (1978) Interactions of vinyl chloride with rat-liver DNA in vivo. Chem.-Biol. Interact. 22, 211-224.
15. 32P-postlabeling. Carcinogenesis 16, 613-617.
16. Schmid, K., Nair, J., Winde, G., Velic, I., and Bartsch, H. (2000) Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients. Int. J. Cancer 87, 1-4.
17. Nair, J., Fürstenberger, G., Bartsch, H., Marks, F., and Bartsch (2000) Promutagenic etheno-DNA adducts in multistage mouse skin carcinogenesis: Correlation with lipoxygenase-catalyzed arachidonic acid metabolism. Chem. Res. Toxicol. 13, 703-709.
18. Simha, D., Palejwala, V. A., and Humayun, M. Z. (1991) Mechanisms of mutagenesis by exocyclic DNA adducts. Construction and in vitro template characteristics of an oligonucleotide bearing a single site-specific ethenocytosine. Biochemistry 30, 8727-8735.
19. 4-ethano-2′-deoxycytidine, and 3-(2-hydroxyethyl)-2′-deoxyuridine. Chem. Res. Toxicol. 8, 157-163.
20. 4-etheno-2′-deoxycytidine in reactions catalyzed by mammalian DNA polymerases. Biochemistry 35, 14992-14998.
21. 4-etheno-C, a potential carcinogenic glycidaldehyde product, miscodes in vitro using mammalian DNA polymerases. Biochemistry 41, 1778-1785.
22. Palejwala, V. A., Simha, D., and Humayun, M. Z. (1991) Mechanisms of mutagenesis by exocyclic DNA adducts. Transfection of M13 viral DNA bearing a site specific adduct shows that ethenocytosine is a highly efficient RecA-independent mutagenic noninstructional lesion. Biochemistry 30, 8736-8743.
23. 4-ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole. Biochemistry 32, 12793-12801.
24. Moriya, M., Zhang, W., Johnson, F., and Grollman, A. P. (1994) Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc. Natl. Acad. Sci. U.S.A. 91, 11899-11903.
25. Esterbauer, H., and Weger, W. (1967) Über die wirkungen von aldehyden aufgesunde und maligne zellen, 3. mitt.: synthese von homologen 4-hydroxy-2-alkenalen, II. Monatsh. Chem. 98, 1994-2000.
26. Barbin, A. (2000) Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra. Mutat. Res. 462, 55-69.
27. Creech, J. L., Jr., and Johnson, M. N. (1974) Angiosarcoma of liver in the manufacture of poly(vinyl chloride). J. Occup. Med. 16, 150-151.
28. Malaveille, C., Bartsch, H., Barbin, A., Camus, A. M., Montesano, R., Croisy, A., and Jacquignon, P. (1975) Mutagenicity of vinyl chloride, chloroethyleneoxide, chloroacetaldehyde and chloroethanol. Biochem. Biophys. Res. Commun. 63, 363-370.
29. 4-ethenocytosine, DNA reaction products of vinyl chloride metabolites, during in vitro DNA synthesis. Nucleic Acids Res. 9, 375-387.
30. Hall, J. A., Saffhill, R., Green, T., and Hathway, D. E. (1981) The induction of errors during in vitro DNA synthesis following chloroacetaldehyde-treatment of poly(dA-dT) and poly(dC-dG) templates. Carcinogenesis 2, 141-146.
31. 4-ethenocytidine in polyribonucleotides. Nucleic Acids Res. 9, 365-373.
32. 4-etheno-2′-deoxycytidine detected by monoclonal antibodies in lung and liver DNA of rats exposed to vinyl chloride. Carcinogenesis 10, 209-212.
33. 2,3-ethenoguanine based on electrophore labeling. Carcinogenesis 11, 1279-1285.
34. Bartsch, H., Barbin, A., Marion, M. J., Nair, J., and Guichard, Y. (1994) Formation, detection, and role in carcinogenesis of ethenobases in DNA. Drug Metab. Rev. 26, 349-371.
35. Bartsch, H., and Nair, J. (2000) New DNA-based biomarkers for oxidative stress and cancer chemoprevention studies. Eur. J. Cancer 36, 1229-1234.
36. 4-ethenocytosine in DNA and in human urine by isotope dilution gas chromatography/negative ion chemical ionization/mass spectrometry. Chem. Res. Toxicol. 14, 1612-1619.
37. Churchwell, M. I., Beland, F. A., and Doerge, D. R. (2002) Quantification of multiple DNA adducts formed through oxidative stress using liquid chromatography and electrospray tandem mass spectrometry. Chem. Res. Toxicol. 15, 1295-1301.
38. 2-ethenodeoxyguanosine as a potential marker for DNA adduct formation by trans-4-hydroxy-2-nonenal. Cancer Res. 48, 320-323.
39. Sodum, R. S., and Chung, F.-L. (1991) Stereoselective formation of in vitro nucleic acid adducts by 2,3-epoxy-4-hydroxynonanal. Cancer Res. 51, 137-143.
40. Chen, H.-J. C., and Chung, F.-L. (1994) Formation of etheno adducts in reactions of enals via autoxidation. Chem. Res. Toxicol. 7, 857-860.
41. 6-etheno-2′-deoxyadenosine adducts from lipid peroxidation products. Chem. Res. Toxicol. 13, 397-405.
42. 2-etheno-2′-deoxyguanosine adduct formation. Chem. Res. Toxicol. 13, 601-609.
43. Burczynski, M. E., Sridhar, G. R., Palackal, N. T., and Penning, T. M. (2001) The reactive oxygen species- and Michael acceptorinducible human aldo-keto reductase AKR1C1 reduces the α,β-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene. J. Biol. Chem. 276, 2890-2897.
44. 2-etheno-2κ-deoxyguanosine adducts. Chem. Res. Toxicol. 15, 300-304.